UniSa - IRIS Institutional Research Information System

RAIMONDO, ANNUNZIATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.755
AS - Asia 3.077
EU - Europa 3.000
SA - Sud America 346
AF - Africa 50
OC - Oceania 4
AN - Antartide 1
Totale 11.233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.693
HK - Hong Kong 1.469
FI - Finlandia 1.199
IT - Italia 1.141
SG - Singapore 783
CN - Cina 308
BR - Brasile 246
VN - Vietnam 192
RU - Federazione Russa 150
FR - Francia 93
DE - Germania 89
IN - India 73
IE - Irlanda 64
KR - Corea 61
NL - Olanda 51
SE - Svezia 48
AR - Argentina 47
GB - Regno Unito 41
JP - Giappone 35
CA - Canada 28
BD - Bangladesh 26
PL - Polonia 20
MX - Messico 19
AT - Austria 18
ES - Italia 17
UA - Ucraina 17
EC - Ecuador 16
TR - Turchia 16
PK - Pakistan 15
CO - Colombia 14
IQ - Iraq 14
CH - Svizzera 13
ID - Indonesia 13
ZA - Sudafrica 10
EG - Egitto 9
HR - Croazia 9
PH - Filippine 9
TN - Tunisia 7
UZ - Uzbekistan 7
VE - Venezuela 7
JO - Giordania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
LT - Lituania 5
MY - Malesia 5
OM - Oman 5
SA - Arabia Saudita 5
AU - Australia 4
CZ - Repubblica Ceca 4
PE - Perù 4
PY - Paraguay 4
BE - Belgio 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IR - Iran 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BH - Bahrain 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MU - Mauritius 1
NE - Niger 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
Totale 11.228
Salva come PNG Salva come JPEG
Città #
Dallas 2.838
Hong Kong 1.465
Helsinki 1.182
San Jose 397
Singapore 374
Chandler 231
Princeton 149
Ashburn 139
Rome 118
Milan 102
Council Bluffs 91
The Dalles 73
Ho Chi Minh City 70
Lauterbourg 70
Beijing 69
Moscow 63
Dublin 62
Naples 60
Ann Arbor 52
Munich 43
Los Angeles 40
Salerno 36
Tokyo 34
Wilmington 34
Hanoi 31
New York 28
São Paulo 28
Amsterdam 26
Genoa 24
Bari 23
Seattle 23
Santa Clara 22
Stockholm 21
Andover 17
Chennai 17
Houston 17
Palermo 17
Warsaw 17
Nuremberg 16
Turin 16
Bologna 15
Jacksonville 15
London 15
Dong Ket 14
Fisciano 14
Montreal 14
Seoul 14
Brooklyn 13
Columbus 13
Denver 13
Orem 13
Boston 12
Mumbai 12
Turku 12
Verona 12
Woodbridge 12
Frankfurt am Main 11
Boardman 10
Cava de' Tirreni 10
Florence 10
Da Nang 9
Pune 9
Albignasego 8
Atlanta 8
Padova 8
West Jordan 8
Belo Horizonte 7
Guangzhou 7
Phoenix 7
Sarno 7
Thái Nguyên 7
Venice 7
Asti 6
Baghdad 6
Buenos Aires 6
Catania 6
Charlotte 6
Haiphong 6
Jakarta 6
Lahore 6
Lamezia Terme 6
Messina 6
Mexico City 6
Napoli 6
Poplar 6
Quito 6
Rio de Janeiro 6
Acerra 5
Addis Ababa 5
Brasília 5
Campinas 5
Domicella 5
Istanbul 5
Izmir 5
Lappeenranta 5
Manchester 5
Marcianise 5
Nanjing 5
Ottaviano 5
Redwood City 5
Totale 8.636
Salva come PNG Salva come JPEG
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 3.976
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 786
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 466
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 439
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 235
Psoriasi eritrodermica: rapida efficacia di bimekizumab 205
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 145
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 135
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 127
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection 125
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 120
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 120
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 118
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 112
Atopic dermatitis: Epidemiology and clinical phenotypes 109
Presence of BAG3 protein in serum samples from patients affected by psoriasis 101
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 98
Interleukin-33: increasing role in dermatological conditions 95
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 92
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 90
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 87
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 83
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review 81
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 79
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 77
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 77
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 76
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 76
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 76
The laboratory role in the assessment of sensitization and irritation potential of cosmetics 75
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 74
IL-33 is regulated by TNF-α in normal and psoriatic skin 74
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 72
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 72
Guselkumab for the treatment of psoriasis 70
A journey into psoriasis: From the adipose tissue to the skin 70
RAST: Clinical applications 69
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 68
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions 68
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 68
Clinical predictors of psoriatic arthritis and osteoclast differentiation 68
A potential prognostic test for bone erosion development in patients with cutaneous predictive sites for psoriatic arthritis 66
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 65
IL-26 in allergic contact dermatitis: Resource in a state of readiness 64
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 63
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 61
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 60
Psoriasis, cardiovascular events, and biologics: Lights and shadows 59
The role of the dermatologist in the immune-mediated/allergic diseases – position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum 59
Photosensitivity and cancer immune-targeted therapies 58
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 58
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 58
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 57
Flash-pumped pulsed dye laser for vascular skin lesions: our experience and an overview of the literature 57
Polymorphic light eruption: What's new in pathogenesis and management 55
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 54
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 53
The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa 49
UVB-induced p53 is reduced by a mixture of natural extracts 49
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 49
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 48
IL-26: A new actor in allergic contact dermatitis 48
Guselkumab e psoriasi in sedi difficili: efficacia ed impatto sulla qualità di vita in pazienti naive o bio experienced 47
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 46
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 46
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 45
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 45
Ultrasonography in the management of a recurrent and eruptive lobular capillary hemangioma and resolution with intense pulsed light 45
New insights into mechanism of Notch signaling in hidradenitis suppurativa 43
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross-sectional study in Italy 42
Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study 41
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 40
Photodermatoses and Skin Cancer 40
Studio osservazionale descrittivo per la valutazione della prevalenza della psoriasi nei pazienti adulti dislipidemici in terapia monoclonale con anti-PCSK9 39
Novel interactions among ultraviolet B, skin and adipose tissue 39
Systemic inflammation: psoriasis as a model…in Naples 39
Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future 38
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 37
Letters to the editor 36
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study 35
Psoriasi e terapia con guselkumab: panoramica 2022 dal centro prescrittore AOU Salerno 35
Dermatite atopica e stress ossidativo: nuovi biomarker 32
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy 31
Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series 29
The role of the RNA-binding protein AUF-1 in chronic inflammatory skin diseases and cellular senescence 24
Totale 11.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 10 8 16
2021/2022255 2 4 3 20 30 2 0 11 21 5 40 117
2022/2023544 55 56 27 74 27 102 6 53 87 15 27 15
2023/2024541 23 54 39 26 35 45 28 46 18 66 54 107
2024/20251.533 65 36 115 137 79 187 169 86 240 88 145 186
2025/20268.271 252 1.644 2.755 316 478 243 648 144 1.389 402 0 0
Totale 11.338